340B概況 (2023年)

由於兩個因素，340B市場的採購能量近年來一直處於高水準：(1)醫療保健提供者加強了成本控制，特別是在藥房等成本中心，以及(2)340供應商擴大了客戶的類型。

本報告提供從2020年10月到2022年10月的醫藥品決策議案 (共49件) 的相關調查，特定的供應商獲得最多購買能源的理由，關於替代的供應商分析。還有可取得的場合，也包含來自目前客戶的滿意度資料。

Purchasing energy in the 340B market has been high in recent years as (1) healthcare organizations have sought to increase savings, particularly in cost centers like pharmacies, and (2) 340B vendors have expanded the types of customers they serve. This report examines 49 recent purchase decisions validated by KLAS between October 2020 and October 2022 to understand why certain vendors are seeing the most purchase energy and who is being replaced. When available, satisfaction data from current customers is also included.